Redhill Biopharma (RDHL) - EPS (earnings per share)

EPS in 2023 (TTM): NZ-$1,163

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is NZ-$1,199. In 2017 the company made an earnings per share (EPS) of NZ-$4,281 a decrease over its 2016 EPS that were of NZ-$3,767.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year	EPS	Change
2023 (TTM)	NZ-$1,163
2017	NZ-$4,281	13.64%
2016	NZ-$3,767	9.12%
2015	NZ-$3,452	68.01%
2014	NZ-$2,055	-25.93%
2013	NZ-$2,774

EPS for similar companies or competitors

Company	EPS	EPS differencediff.	Country
Sanofi SNY	NZ$6.35	-100.53%	🇫🇷 France
Merck MRK	NZ$13.00	-101.08%	🇺🇸 USA
GlaxoSmithKline GSK	NZ$6.16	-100.51%	🇬🇧 UK
Taro Pharmaceutical TARO	NZ$2.09	-100.17%	🇮🇱 Israel
Teva Pharmaceutical Industries TEVA	NZ$1.08	-100.09%	🇮🇱 Israel

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): NZ-$1,163